These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1409090)

  • 1. Texture analysis of histological images of giant cell tumor of bone.
    Kuwahara H; Shimazaki M; Morikita I; Chanoki Y; Sakurai M
    Pathol Res Pract; 1992 Jun; 188(4-5):565-9. PubMed ID: 1409090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative pathological study of aggressiveness of giant cell tumor of bone.
    Sun DQ; Feng CH; Fang JQ; Biesterfeld S; Boecking A
    Chin Med J (Engl); 1991 Apr; 104(4):281-7. PubMed ID: 2065544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to a computer analysis of histologic images of giant cell tumor of bone and osteosarcoma.
    Chanoki Y; Shimazaki M; Mitsuhashi T; Kuwahara H; Kanno T; Ishida T; Shimazu A; Yamashita K
    Osaka City Med J; 1984 Dec; 30(2):147-59. PubMed ID: 6598866
    [No Abstract]   [Full Text] [Related]  

  • 4. Thallium-201 Uptake of Giant Cell Tumor: One Step Toward the Differential Diagnosis to Atypically Presenting Osteosarcoma.
    Keller S; Inai R; Sato S; Tada A; Adam G; Yamamura J; Kanazawa S
    AJR Am J Roentgenol; 2017 Jan; 208(1):171-179. PubMed ID: 27726429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation index and vascular density of giant cell tumors of bone: are they prognostic markers?
    Sulh MA; Greco MA; Jiang T; Goswami SB; Present D; Steiner G
    Cancer; 1996 May; 77(10):2044-51. PubMed ID: 8640668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
    Roessner A; Grundmann E
    Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant tumors primary in bone (osteosarcoma, chondrosarcoma, fibrosarcoma, malignant giant cell tumor).
    Bonfiglio M
    Proc Natl Cancer Conf; 1970; 6():721-30. PubMed ID: 5272232
    [No Abstract]   [Full Text] [Related]  

  • 9. Needle biopsy of primary malignant bone tumors.
    Hajdu SI; Melamed MR
    Surg Gynecol Obstet; 1971 Nov; 133(5):829-32. PubMed ID: 4939087
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant bone tumors of the lower extremity.
    Buxbaum FD
    J Foot Surg; 1976; 15(3):85-92. PubMed ID: 1071753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of bone tumors in Mexico City: retrospective clinicopathologic study of 566 patients at a referral institution.
    Baena-Ocampo Ldel C; Ramirez-Perez E; Linares-Gonzalez LM; Delgado-Chavez R
    Ann Diagn Pathol; 2009 Feb; 13(1):16-21. PubMed ID: 19118777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous malignant transformation of conventional giant cell tumor.
    Grote HJ; Braun M; Kalinski T; Pomjanski N; Back W; Bleyl U; Böcking A; Roessner A
    Skeletal Radiol; 2004 Mar; 33(3):169-75. PubMed ID: 14749901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative pathologic consultation (IOC) for tumors of the bone.
    Mirra JM; Brien EW; Luck JV
    Chir Organi Mov; 1997; 82(1):7-31. PubMed ID: 9269110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix vesicles in bone tumors. Ultrastructural analysis and their significance in neoplastic bone formation.
    Yoshida H; Miyazaki S; Yumoto T
    Acta Pathol Jpn; 1991 Aug; 41(8):610-7. PubMed ID: 1661059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of bone GLA protein in primary bone tumors.
    Iwasaki R; Yamamuro T; Kotoura Y; Okumura H; Kasai R; Nakashima Y
    Cancer; 1992 Aug; 70(3):619-24. PubMed ID: 1320449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential diagnosis of giant cell tumor of bone].
    Salzer-Kuntschik M
    Verh Dtsch Ges Pathol; 1998; 82():154-9. PubMed ID: 10095427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New cytomorphologic methods in the diagnosis of bone tumors: possibilities and limitations.
    Roessner A; Mellin W; Hiddemann W; Voss B; Vollmer E; Grundmann E
    Semin Diagn Pathol; 1984 Aug; 1(3):199-214. PubMed ID: 6600111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bone morphogenetic proteins in giant cell tumor of bone.
    Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
    Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Dedifferentiation" in bone and soft-tissue tumors. A histological indicator of tumor progression.
    Meis JM
    Pathol Annu; 1991; 26 Pt 1():37-62. PubMed ID: 2014144
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
    el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
    Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.